-
81 new Chinese medicine pieces will be included in the province's medical insurance payment coverage
Time of Update: 2022-10-25
js?cdnversion='+~(-new Date()/36e5)]; In recent years, traditional Chinese medicine has received different degrees of policy support in terms of strategic position, standardized development mode, price, payment end, medical insurance immunization, sales end and innovation rhythm.
-
How is mNGS used in infectious diseases? This is the best interpretation I've ever seen
Time of Update: 2022-10-13
Infectious diseases refer to local or systemic inflammation or organ dysfunction caused by bacteria, viruses, fungi, atypical pathogens, parasites, etc. and their products, which have great harm and h
-
What is the state of your ten years of medical practice
Time of Update: 2022-10-13
The value and sense of mission of "serving the doctors, improving medical care" are the most attractive places.
-
This pharmaceutical stock is "bull
Time of Update: 2022-04-16
Looking back at 2021, the overall performance of the pharmaceutical sector in the A-share market is weak, and the stock prices of pharmaceutical giants such as Hengrui Medicine cannot avoid a relatively large adjustment .
-
The tax storm hit, 14 pharmaceutical companies were notified
Time of Update: 2022-02-21
Judging from the nature of the case, this violation mainly focused on "falsely issuing special VAT invoices", and 7 pharmaceutical companies violated the rules .
-
Once this organ is involved, is the risk of death significantly increased in patients with Sjögren's syndrome
Time of Update: 2022-01-25
*Only for medical professionals to read the latest information on Sjögren's syndrome pulmonary lesions! Sjögren's syndrome (SS) is a diffuse autoimmune disease characterized by invasion of exocrine g
-
US$6.5 billion acquisition of the company to obtain Johnson & Johnson's new FcRn antibody drug approved for clinical use in China
Time of Update: 2021-11-05
Text|Pharmaceutical Mission HillsThe Center for Drug Evaluation (CDE) of the National Medical Products Administration of China revealed that the new class 1 drug nipocalimab injection declared by Johnson & Johnson's Janssen company has obtained a clinical trial implied license, and plans to develop a treatment for systemic type.
-
DuPont adds multiple medical-grade elastomer mixing equipment
Time of Update: 2021-11-01
The investment includes the addition of a new molded component production facility; the construction of a new biopharmaceutical process pipeline medical and health base in the Cooper River area of South Carolina, USA; and the increase of local production capacity of biopharmaceutical process pipelines in China .
-
The average price of artificial joints is reduced by 82
Time of Update: 2021-09-19
Movement Movement In the first year of the centralized procurement of artificial joints, the intended purchase amount was 540,000 sets, which accounted for 90% of the total demand of medical institutions nationwide .
-
Sweden's health products exports grow
Time of Update: 2021-07-30
Maria Helling, CEO of Swecare, said that many Swedish export companies have seen their business shrink, but for medical products and health products companies, it has been a year of rising profits .
-
Qilu broke out
Time of Update: 2021-06-10
A few days ago, the State Food and Drug Administration's official website showed that Qilu Pharmaceutical's cefazolin sodium for injection has been approved as a supplementary application, and this product is the third domestically-evaluated company.
-
STING agonist to block the new coronavirus in the body's first line of defense shows the potential to prevent infection
Time of Update: 2021-06-06
Moreover, the target of this drug is a protein expressed by the human body itself, so it will not be affected by the mutation of the new coronavirus, and it may temporarily increase the immune response of the respiratory tract and lung epithelial cells to have an effect on the virus that causes a variety of respiratory diseases .
-
Chinese and American researchers have developed artificial intelligence that can examine retinal diseases
Time of Update: 2021-03-08
researchers at Guangzhou Women's and Children's Medical Center and the University of California, San Diego and others studied more than 200,000 eye optically relevant fault scans using reel neural networks based on artificial intelligence technology.
-
Beda Pharmaceuticals listed two years of continuous decline in performance, trapped in the "one drug, one big" dilemma
Time of Update: 2021-02-27
third-quarter results showed that Bayda Pharmaceuticals reported revenue of 928 million yuan in the first three quarters, up 20.74 percent from a year earlier, while net profit attributable to shareholders of listed companies was 148 million yuan, down 27.37 percent from a year earlier.
-
NEJM: Once a week, weight loss therapy is a big breakthrough
Time of Update: 2021-02-24
recently, follow-up analysis data from a randomized controlled trial showed that weight loss surgery was more effective in long-term control of type 2 diabetes (T2DM) than traditional medical treatment, with 37.5 percent of patients undergoing surgery maintaining HbA1c until 7.0 percent after 10 years.
